share_log

JMP Securities Reiterates Market Outperform on Cellectis, Maintains $6 Price Target

JMP Securities Reiterates Market Outperform on Cellectis, Maintains $6 Price Target

JMP Securities重申Cellectis的市场表现跑赢大盘,维持6美元的目标股价
Benzinga ·  2023/08/07 08:58

JMP Securities analyst Silvan Tuerkcan reiterates Cellectis (NASDAQ:CLLS) with a Market Outperform and maintains $6 price target.

JMP证券分析师Silvan Tuerkcan重申Cellectis(纳斯达克:CLLS)的市场表现强于大盘,并维持6美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发